Here is a summary of the clinical note in 500 words or less:

**Patient Information:**

* Female patient, age not specified
* Admitted to the hospital with sepsis and fever
* History of metastatic pancreatic adenocarcinoma (PDAC) with lung recurrence

**Medical History:**

* Initially presented with transaminitis and malignant CBD stricture
* Received neoadjuvant FOLFIRINOX, SBRT, and Whipple procedure
* Final pathologic staging was T1N0 with positive margins and lymph node invasion
* Received adjuvant FOLFOX and was enrolled in a Phase I trial of RX-3117 and abraxane

**Present Illness:**

* Presented with fever and found to have GNR bacteremia and E. coli UTI
* Received CT A/P, which did not show any intraabdominal source of infection
* Started on zosyn and transferred to the hospital for further management

**Physical Exam:**

* Vital signs were normal
* General: Well-appearing, pleasant Caucasian woman
* Neuro: Alert, oriented to person, place, and time
* HEENT: Oropharynx clear, no palpable cervical or supraclavicular adenopathy
* Cardiovascular: Regular rate and rhythm, soft systolic murmur
* Chest/Pulmonary: Clear to auscultation bilaterally
* Abdomen: Soft, nontender, nondistended, bowel sounds present

**Laboratory Results:**

* Admission labs: WBC 7.0, RBC 2.59, Hgb 8.1, Hct 24.2, MCV 93, MCH 31.3, MCHC 33.5, RDW 16.7
* Discharge labs: WBC 22.9, RBC 2.66, Hgb 8.3, Hct 25.5, MCV 96, MCH 31.2, MCHC 32.5, RDW 17.9

**Microbiology:**

* Blood culture: Klebsiella pneumoniae
* Urine culture: E. coli

**Imaging:**

* CXR: No evidence of active disease
* CT Abdomen/Pelvis: Bilateral pulmonary nodules, no acute abdominal pelvic process

**Discharge:**

* Discharged on ciprofloxacin for 14 days to complete treatment for Klebsiella bacteremia and E. coli UTI
* Continued home medications for metastatic pancreatic adenocarcinoma, anemia, leukocytosis, HLP, hypothyroidism, GERD, and depression

**Follow-up:**

* Follow-up pending blood cultures and urine culture
* Follow-up with outpatient team for further management of metastatic pancreatic adenocarcinoma